QL
XERS icon

Quarry LP’s Xeris Biopharma Holdings XERS Stock Holding History

Quarry LP’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.19M Buy
150,057
+25,057
+20% +$160K 0.1% 79
2026
Q1 		$725K Buy
125,000
+45,000
+56% +$298K 0.13% 123
2025
Q4 		$628K Sell
80,000
-2,500
-3% -$19.7K 0.1% 117
2025
Q3 		$672K Sell
82,500
-80,000
-49% -$531K 0.15% 104
2025
Q2 		$759K Buy
162,500
+91,749
+130% +$420K 0.16% 113
2025
Q1 		$388K Buy
+70,751
New +$286K 0.08% 205
2024
Q3 		– Sell
-30,000
Closed -$67.5K – 2135
2024
Q2 		$67.5K Buy
30,000
+500
+2% +$1.01K 0.02% 512
2024
Q1 		$65.2K Buy
29,500
+9,500
+48% +$24.6K 0.01% 349
2023
Q4 		$47K Buy
+20,000
New +$36.9K 0.01% 350

Other funds holding XERS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Quarry LP's XERS Position: Q2 2026 in Review

Quarry LP increased its Xeris Biopharma Holdings (XERS) stake by 20% in Q2 2026, buying an estimated $160K and bringing the position to 150,057 shares worth $1.19M. The position accounts for 0.1% of the portfolio, ranked #79.

Quarry LP first reported a position in XERS in Q4 2023 and has held it in 9 quarters since. 241 funds tracked by Wall St. Rank hold XERS as of Q2 2026.

  • Quarry LP held 150,057 shares of Xeris Biopharma Holdings worth $1.19M as of Q2 2026.
  • Quarry LP bought 25,057 Xeris Biopharma Holdings shares in Q2 2026, an estimated $160K.
  • Xeris Biopharma Holdings made up 0.1% of Quarry LP's portfolio in Q2 2026, its #79 holding.
  • Quarry LP first reported a position in Xeris Biopharma Holdings in Q4 2023 and has held it in 9 quarters since.
  • 241 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q2 2026.

Based on Quarry LP's 13F filing for Q2 2026, filed 14 Aug 2026.